These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 10497989)

  • 1. The development of an immunoassay for the detection of artemisinin compounds in urine.
    Eggelte TA; van Agtmael MA; Vuong TD; van Boxtel CJ
    Am J Trop Med Hyg; 1999 Sep; 61(3):449-56. PubMed ID: 10497989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of a novel monoclonal antibody against the antimalarial drugs, artemisinin and artesunate.
    Tanaka H; Putalun W; De-Eknamkul W; Matangkasombut O; Shoyama Y
    Planta Med; 2007 Aug; 73(10):1127-32. PubMed ID: 17611929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid evaluation of artesunate quality with a specific monoclonal antibody-based lateral flow dipstick.
    Guo S; Zhang W; He L; Tan G; Min M; Kyaw MP; Wang B; Cui L
    Anal Bioanal Chem; 2016 Sep; 408(22):6003-8. PubMed ID: 26873200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a colloidal gold-based lateral flow dipstick immunoassay for rapid qualitative and semi-quantitative analysis of artesunate and dihydroartemisinin.
    He L; Nan T; Cui Y; Guo S; Zhang W; Zhang R; Tan G; Wang B; Cui L
    Malar J; 2014 Mar; 13():127. PubMed ID: 24678609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Authentication of artemether, artesunate and dihydroartemisinin antimalarial tablets using a simple colorimetric method.
    Green MD; Mount DL; Wirtz RA
    Trop Med Int Health; 2001 Dec; 6(12):980-2. PubMed ID: 11737833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of monoclonal antibody-based immunoassays for quantification and rapid assessment of dihydroartemisinin contents in antimalarial drugs.
    Ning X; Li W; Wang M; Guo S; Tan G; Wang B; Cui L
    J Pharm Biomed Anal; 2018 Sep; 159():66-72. PubMed ID: 29980021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combined antimalarial therapy using artemisinin].
    Majori G
    Parassitologia; 2004 Jun; 46(1-2):85-7. PubMed ID: 15305693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a sensitive monoclonal antibody-based enzyme-linked immunosorbent assay for the antimalaria active ingredient artemisinin in the Chinese herb Artemisia annua L.
    He SP; Tan GY; Li G; Tan WM; Nan TG; Wang BM; Li ZH; Li QX
    Anal Bioanal Chem; 2009 Feb; 393(4):1297-303. PubMed ID: 19066864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple dose study of interactions between artesunate and artemisinin in healthy volunteers.
    Zhang SQ; Hai TN; Ilett KF; Huong DX; Davis TM; Ashton M
    Br J Clin Pharmacol; 2001 Oct; 52(4):377-85. PubMed ID: 11678781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of a single-chain variable fragment and a recombinant antigen-binding fragment against the anti-malarial drugs, artemisinin and artesunate, and their application in an ELISA.
    Paudel MK; Takei A; Sakoda J; Juengwatanatrakul T; Sasaki-Tabata K; Putalun W; Shoyama Y; Tanaka H; Morimoto S
    Anal Chem; 2012 Feb; 84(4):2002-8. PubMed ID: 22260329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrarectal artemisinin derivatives.
    Nosten F; van Vugt M; White NJ
    Med Trop (Mars); 1998; 58(3 Suppl):63-4. PubMed ID: 10212903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rectal administration of artemisinin derivatives for the treatment of malaria.
    Karunajeewa HA; Manning L; Mueller I; Ilett KF; Davis TM
    JAMA; 2007 Jun; 297(21):2381-90. PubMed ID: 17551131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacology and therapeutic potential of artemisinin and its derivatives in the treatment of malaria.
    de Vries PJ; Dien TK
    Drugs; 1996 Dec; 52(6):818-36. PubMed ID: 8957153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a lateral flow dipstick for simultaneous and semi-quantitative analysis of dihydroartemisinin and piperaquine in an artemisinin combination therapy.
    Ning X; Tan G; Chen X; Wang M; Wang B; Cui L
    Drug Test Anal; 2019 Sep; 11(9):1444-1452. PubMed ID: 31150570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimalarial activity of dihydroartemisinin derivatives by transdermal application.
    Lin AJ; Ager AL; Klayman DL
    Am J Trop Med Hyg; 1994 Jun; 50(6):777-83. PubMed ID: 8024074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of ELISA for quantitation of artemisinin-based antimalarial drugs.
    Wang M; Cui Y; Zhou G; Yan G; Cui L; Wang B
    Am J Trop Med Hyg; 2013 Dec; 89(6):1122-8. PubMed ID: 24080636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extraction of artemisinin and artemisinic acid: preparation of artemether and new analogues.
    Haynes RK; Vonwiller SC
    Trans R Soc Trop Med Hyg; 1994 Jun; 88 Suppl 1():S23-6. PubMed ID: 8053018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The rational use of qinghaosu and its derivatives: what is the future of new compounds?
    Looareesuwan S; Wilairatana P
    Med Trop (Mars); 1998; 58(3 Suppl):89-92. PubMed ID: 10212910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a Specific Monoclonal Antibody for the Quantification of Artemisinin in Artemisia annua and Rat Serum.
    Guo S; Cui Y; Wang K; Zhang W; Tan G; Wang B; Cui L
    Anal Chem; 2016 Mar; 88(5):2701-6. PubMed ID: 26822789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
    West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
    Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.